Telix and ITM Announce $1.65B Radiopharmaceutical Merger
Melbourne, Australia; Indianapolis, U.S.; Munich, Germany, September 21, 2026 Telix Pharmaceuticals Limited has announced a strategic agreement to lead...
GEP-NETs
Advertisement
Curium Gains FDA Approval for BEXLUTRY in GEP-NETs
BOSTON, Mass. — September 14, 2026 Curium™ announced that the U.S. Food and Drug Administration (FDA) has approved its...
ITM Receives FDA Complete Response Letter for ITM-11
Garching/Munich, Germany and Princeton, New Jersey, August 10, 2026 ITM Isotope Technologies Munich SE (ITM) announced that the U.S....
Teva Highlights Long-Term AUSTEDO Success in Tardive Dyskinesia Care
PARSIPPANY, N.J. and TEL AVIV, Israel, June 20, 2026 Teva Pharmaceutical Industries Ltd. has unveiled compelling new long-term data...
Curium Court Victory Clears Path for U.S. GEP-NET Therapy
BOSTON, MA, June 18, 2026 Curium™ has secured a significant legal and commercial milestone after prevailing in a patent...
Advertisement
